News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
78 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19238)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1714)
Day
1 (121)
2 (97)
3 (8)
5 (6)
6 (79)
7 (151)
8 (89)
9 (80)
10 (30)
13 (139)
14 (106)
15 (102)
16 (135)
17 (48)
19 (25)
20 (84)
21 (88)
22 (116)
23 (109)
24 (78)
26 (6)
27 (17)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
IPO
Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech
Jennifer Doudna–founded Scribe Therapeutics intends to use the proceeds from the public offering—the first for a gene editing outfit in over two years—to support development of its epigenetic silencing therapy for atherosclerotic cardiovascular disease.
July 24, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Crux Collaborates with Novo Nordisk to Offer Access to Wegovy® and Other Obesity Management Medications
July 24, 2026
·
2 min read
Press Releases
Enveda’s Positive Phase 1B Results for ENV-294, a Potential First-in-Class Oral Therapy for Moderate-to-Severe Atopic Dermatitis, Were Presented at AAD Innovation Academy; Additional Details to Be Shared at EADV
July 24, 2026
·
4 min read
Press Releases
Phillips Medisize to Present Strategies for Scaling Complex In Vitro Diagnostic (IVD) Builds Through Structured CDMO Collaboration at ADLM 2026
July 24, 2026
·
2 min read
Press Releases
Feinstein Institutes Researchers Honored With Seven Prestigious Awards at the 2026 Shock Society Annual Conference
July 24, 2026
·
3 min read
Press Releases
Guerbet : H1 2026 revenue.
July 24, 2026
·
12 min read
Press Releases
Apertura Gene Therapy Named to Consortium Receiving Funding from the Advanced Research Projects Agency for Health (ARPA-H) THRIVE Program to Develop Gene Therapies for Rare Childhood Diseases
July 24, 2026
·
4 min read
Press Releases
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
July 24, 2026
·
4 min read
Press Releases
Recent Patent and Court Developments in the U.S. and Europe Reinforce Danone’s Patent Position as Global Commercialization of Akkermansia MucT® Expands
July 24, 2026
·
5 min read
Press Releases
Lilac Biosciences and Soin Neuroscience Announce Publication of Clinical Review on RNA Biomarkers for Neuropathic Pain
July 24, 2026
·
3 min read
1 of 8
Next
